CIPLA vs NGLFINE: Stock Comparison

Cipla Ltd vs NGL Fine-Chem Limited

Live data: 22 July 2026, 2:37 PM IST • Source: NSE and company filings

Cipla Ltd is the larger company by market capitalisation. Cipla Ltd shows a lower P/E, a higher dividend yield and lower leverage, while NGL Fine-Chem Limited shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Cipla Ltd and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, CIPLA is more favourable on 6 of 13 scored metrics and NGLFINE on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
CIPLA is the larger company
₹1.14 L Cr vs ₹1,996 Cr
P/E Ratio
CIPLA has a lower P/E
29.83x vs 41.23x
P/B Ratio
CIPLA has a lower P/B
3.36x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹48.01
Dividend Yield
CIPLA has a higher dividend yield
0.9% vs 0.05%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs -2.1%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -54.6%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -2.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCIPLANGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricCIPLANGLFINE
Live Price₹1,411.4₹3,248.1
Day Change-1.47%0.33%
Volume12.91 L4,226
52-Week High₹1,673₹3,329
52-Week Low₹1,165.7₹1,175.5
Distance from 52W High-15.64%-2.43%

Valuation

MetricCIPLANGLFINE
Market Cap₹1.14 L Cr₹1,996 Cr
P/E Ratio29.83x41.23x
P/B Ratio3.36x6.03x
EPS₹48.01₹78.04
Book Value₹426.25₹532.95
Dividend Yield0.9%0.05%

Growth

MetricCIPLANGLFINE
Revenue Growth (TTM YoY)-2.1%57.2%
EPS Growth (TTM YoY)-54.6%1,539.8%
Qtr Sales Growth-2.8%57.1%
Qtr Profit Growth-54.6%2,398%

Profitability & Leverage

MetricCIPLANGLFINE
ROE11.6%15.7%
ROCE15.5%17%
Net Margin13.96%9.59%
Operating Margin20.9%14.5%
Debt to Equity0.02x0.33x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricCIPLANGLFINE
Promoter Holding9.17%72.74%
FII Holding22.56% 1.37 pp0.03% 0.03 pp
DII Holding31.97% 1.25 pp0%
Public Holding16.25% 0.12 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Cipla Ltd and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.